Brain-derived neurotrophic factor and neuroplasticity in bipolar disorder

References

• Kessler RC, McGonagle KA, Zhao S et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch. Gen. Psychiatry51(1), 8–19 (1994).
   PubMed Web of Science ®Google Scholar
• Bliss TV, Collingridge GL. A synaptic model of memory: long-term potentiation in the hippocampus. Nature361(6407), 31–39 (1993).
   PubMed Web of Science ®Google Scholar
• Kuipers SD, Bramham CR. Brain-derived neurotrophic factor mechanisms and function in adult synaptic plasticity: new insights and implications for therapy. Curr. Opin. Drug Discov. Dev.9(5), 580–586 (2006).
   PubMedGoogle Scholar
• Martinowich K, Manji H, Lu B. New insights into BDNF function in depression and anxiety. Nat. Neurosci.10(9), 1089–1093 (2007).
   PubMed Web of Science ®Google Scholar
• Timmusk T, Palm K, Metsis M et al. Multiple promoters direct tissue-specific expression of the rat BDNF gene. Neuron10(3), 475–489 (1993).
   PubMed Web of Science ®Google Scholar
• Martinowich K, Hattori D, Wu H et al. DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science302(5646), 890–893 (2003).
   PubMed Web of Science ®Google Scholar
• Tsankova NM, Berton O, Renthal W, Kumar A, Neve RL, Nestler EJ. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat. Neurosci.9(4), 519–525 (2006).
   PubMed Web of Science ®Google Scholar
• Yasuda S, Liang MH, Marinova Z, Yahyavi A, Chuang DM. The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons. Mol. Psychiatry (2007) (Epub ahead of print).
   Google Scholar
• Lu B, Pang PT, Woo NH. The yin and yang of neurotrophin action. Nat. Rev. Neurosci.6(8), 603–614 (2005).
   PubMed Web of Science ®Google Scholar
• Chen ZY, Ieraci A, Teng H et al. Sortilin controls intracellular sorting of brain-derived neurotrophic factor to the regulated secretory pathway. J. Neurosci.25(26), 6156–6166 (2005).
   PubMedGoogle Scholar
• Chen ZY, Jing D, Bath KG et al. Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science314(5796), 140–143 (2006).
   PubMed Web of Science ®Google Scholar
• Huang EJ, Reichardt LF. Neurotrophins: roles in neuronal development and function. Annu. Rev. Neurosci.24, 677–736 (2001).
   PubMed Web of Science ®Google Scholar
• Bramham CR, Messaoudi E. BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis. Prog. Neurobiol.76(2), 99–125 (2005).
   PubMed Web of Science ®Google Scholar
• Shaltiel G, Chen G, Manji HK. Neurotrophic signaling cascades in the pathophysiology and treatment of bipolar disorder. Curr. Opin. Pharmacol.7(1), 22–26 (2007).
   PubMed Web of Science ®Google Scholar
• Blum R, Konnerth A. Neurotrophin-mediated rapid signaling in the central nervous system: mechanisms and functions. Physiology20, 70–78 (2005).
   PubMed Web of Science ®Google Scholar
• Jovanovic JN, Czernik AJ, Fienberg AA, Greengard P, Sihra TS. Synapsins as mediators of BDNF-enhanced neurotransmitter release. Nat. Neurosci.3(4), 323–329 (2000).
   PubMed Web of Science ®Google Scholar
• Levine ES, Crozier RA, Black IB, Plummer MR. Brain-derived neurotrophic factor modulates hippocampal synaptic transmission by increasing N-methyl-D-aspartic acid receptor activity. Proc. Natl Acad. Sci. USA95(17), 10235–10239 (1998).
   PubMed Web of Science ®Google Scholar
• Castren E. Is mood chemistry? Nat. Rev. Neurosci.6(3), 241–246 (2005).
   PubMed Web of Science ®Google Scholar
• Berton O, Nestler EJ. New approaches to antidepressant drug discovery: beyond monoamines. Nat. Rev. Neurosci.7(2), 137–151 (2006).
   PubMed Web of Science ®Google Scholar
• Cunha AB, Frey BN, Andreazza AC et al. Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes. Neurosci. Lett.398(3), 215–219 (2006).
   PubMed Web of Science ®Google Scholar
• Machado-Vieira R, Dietrich MO, Leke R et al. Decreased plasma brain derived neurotrophic factor levels in unmedicated bipolar patients during manic episode. Biol. Psychiatry61(2), 142–144 (2007).
   PubMed Web of Science ®Google Scholar
• Manji HK, Quiroz JA, Sporn J et al. Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression. Biol. Psychiatry53(8), 707–742 (2003).
   PubMed Web of Science ®Google Scholar
• Manji HK, Duman RS. Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics. Psychopharmacol. Bull.35(2), 5–49 (2001).
   PubMedGoogle Scholar
• Strakowski SM, Adler CM, DelBello MP. Volumetric MRI studies of mood disorders: do they distinguish unipolar and bipolar disorder? Bipolar Disord.4(2), 80–88 (2002).
   PubMed Web of Science ®Google Scholar
• Martinez-Aran A, Vieta E, Reinares M et al. Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. Am. J. Psychiatry161(2), 262–270 (2004).
   PubMed Web of Science ®Google Scholar
• Thompson JM, Gallagher P, Hughes JH et al. Neurocognitive impairment in euthymic patients with bipolar affective disorder. Br. J. Psychiatry186, 32–40 (2005).
   PubMed Web of Science ®Google Scholar
• Robinson LJ, Thompson JM, Gallagher P et al. A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder. J. Affect. Disord.93(1–3), 105–115 (2006).
   PubMed Web of Science ®Google Scholar
• Martinez-Aran A, Vieta E, Torrent C et al. Functional outcome in bipolar disorder: the role of clinical and cognitive factors. Bipolar Disord.9(1–2), 103–113 (2007).
   PubMed Web of Science ®Google Scholar
• Mueser KT, Rosenberg SD, Goodman LA, Trumbetta SL. Trauma, PTSD, and the course of severe mental illness: an interactive model. Schizophr. Res.53(1–2), 123–143 (2002).
   PubMed Web of Science ®Google Scholar
• McCauley J, Kern DE, Kolodner K et al. Clinical characteristics of women with a history of childhood abuse: unhealed wounds. JAMA277(17), 1362–1368 (1997).
   PubMed Web of Science ®Google Scholar
• Agid O, Kohn Y, Lerer B. Environmental stress and psychiatric illness. Biomed. Pharmacother.54(3), 135–141 (2000).
   PubMed Web of Science ®Google Scholar
• Post RM, Leverich GS. The role of psychosocial stress in the onset and progression of bipolar disorder and its comorbidities: the need for earlier and alternative modes of therapeutic intervention. Dev. Psychopathol.18(4), 1181–1211 (2006).
   PubMed Web of Science ®Google Scholar
• Arnow BA. Relationships between childhood maltreatment, adult health and psychiatric outcomes, and medical utilization. J. Clin. Psychiatry65(Suppl. 12), 10–15 (2004).
   PubMed Web of Science ®Google Scholar
• Gomez-Pinilla F, Vaynman S. A “deficient environment” in prenatal life may compromise systems important for cognitive function by affecting BDNF in the hippocampus. Exp. Neurol.192(2), 235–243 (2005).
   PubMed Web of Science ®Google Scholar
• Duman RS, Monteggia LM. A neurotrophic model for stress-related mood disorders. Biol. Psychiatry59(12), 1116–1127 (2006).
   PubMed Web of Science ®Google Scholar
• Savitz J, van der Merwe L, Stein DJ, Solms M, Ramesar R. Genotype and childhood sexual trauma moderate neurocognitive performance: a possible role for brain-derived neurotrophic factor and apolipoprotein E variants. Biol. Psychiatry62(5), 391–399 (2007).
   PubMed Web of Science ®Google Scholar
• Kaufman J, Yang BZ, Douglas-Palumberi H et al. Brain-derived neurotrophic factor-5-HTTLPR gene interactions and environmental modifiers of depression in children. Biol. Psychiatry59(8), 673–680 (2006).
   PubMed Web of Science ®Google Scholar
• Kauer-Sant’anna M, Tramontina JF, Andreazza AC et al. Traumatic life events in bipolar disorder: impact on BDNF levels and psychopatology. Bipolar Disord.9(Suppl. 1), 128–135 (2007).
   PubMedGoogle Scholar
• Breslau N, Lucia VC, Alvarado GF. Intelligence and other predisposing factors in exposure to trauma and posttraumatic stress disorder: a follow-up study at age 17 years. Arch. Gen. Psychiatry63(11), 1238–1245 (2006).
   PubMed Web of Science ®Google Scholar
• Schmidt HD, Duman RS. The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior. Behav. Pharmacol.18(5–6), 391–418 (2007).
   PubMed Web of Science ®Google Scholar
• Duval F, Crocq MA, Guillon MS et al. Increased adrenocorticotropin suppression following dexamethasone administration in sexually abused adolescents with posttraumatic stress disorder. Psychoneuroendocrinology29(10), 1281–1289 (2004).
   PubMed Web of Science ®Google Scholar
• Grassi-Oliveira R, Ohashi K, Polcari A et al. Harsh corporal punishment associated with enduring alterations in hormonal and cardiac response to stress challenge. Biol. Psychiatry61, 45S (2007).
   Google Scholar
• Schule C, Zill P, Baghai TC et al. Brain-derived neurotrophic factor Val66Met polymorphism and dexamethasone/CRH test results in depressed patients. Psychoneuroendocrinology31(8), 1019–1025 (2006).
   PubMed Web of Science ®Google Scholar
• McEwen BS. Effects of adverse experiences for brain structure and function. Biol. Psychiatry48(8), 721–731 (2000).
   PubMed Web of Science ®Google Scholar
• Maroun M. Stress reverses plasticity in the pathway projecting from the ventromedial prefrontal cortex to the basolateral amygdala. Eur J. Neurosci.24(10), 2917–2922 (2006).
   PubMedGoogle Scholar
• Jay TM, Rocher C, Hotte M, Naudon L, Gurden H, Spedding M. Plasticity at hippocampal to prefrontal cortex synapses is impaired by loss of dopamine and stress: importance for psychiatric diseases. Neurotox. Res.6(3), 233–244 (2004).
   PubMed Web of Science ®Google Scholar
• Brown SM, Henning S, Wellman CL. Mild, short-term stress alters dendritic morphology in rat medial prefrontal cortex. Cereb. Cortex15(11), 1714–1722 (2005).
   PubMed Web of Science ®Google Scholar
• Czeh B, Simon M, Schmelting B, Hiemke C, Fuchs E. Astroglial plasticity in the hippocampus is affected by chronic psychosocial stress and concomitant fluoxetine treatment. Neuropsychopharmacology31(8), 1616–1626 (2006).
   PubMed Web of Science ®Google Scholar
• Vyas A, Bernal S, Chattarji S. Effects of chronic stress on dendritic arborization in the central and extended amygdala. Brain Res.965(1–2), 290–294 (2003).
   PubMed Web of Science ®Google Scholar
• McEwen BS. Glucocorticoids, depression, and mood disorders: structural remodeling in the brain. Metabolism54(5 Suppl. 1), 20–23 (2005).
   PubMed Web of Science ®Google Scholar
• Smith MA, Makino S, Kvetnansky R, Post RM. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J. Neurosci.15(3 Pt 1), 1768–1777 (1995).
   PubMed Web of Science ®Google Scholar
• Ueyama T, Kawai Y, Nemoto K, Sekimoto M, Tone S, Senba E. Immobilization stress reduced the expression of neurotrophins and their receptors in the rat brain. Neurosci. Res.28(2), 103–110 (1997).
   PubMed Web of Science ®Google Scholar
• Vythilingam M, Heim C, Newport J et al. Childhood trauma associated with smaller hippocampal volume in women with major depression. Am. J. Psychiatry159(12), 2072–2080 (2002).
   PubMed Web of Science ®Google Scholar
• Rattiner LM, Davis M, Ressler KJ. Brain-derived neurotrophic factor in amygdala-dependent learning. Neuroscientist11(4), 323–333 (2005).
   PubMedGoogle Scholar
• Dranovsky A, Hen R. Hippocampal neurogenesis: regulation by stress and antidepressants. Biol. Psychiatry59(12), 1136–1143 (2006).
   PubMed Web of Science ®Google Scholar
• Post RM. Role of BDNF in bipolar and unipolar disorder: clinical and theoretical implications. J. Psychiatr. Res.41(12), 979–990 (2007).
   PubMed Web of Science ®Google Scholar
• Rybakowski JK, Borkowska A, Czerski PM, Skibinska M, Hauser J. Polymorphism of the brain-derived neurotrophic factor gene and performance on a cognitive prefrontal test in bipolar patients. Bipolar Disord.5(6), 468–472 (2003).
   PubMedGoogle Scholar
• Green EK, Raybould R, Macgregor S et al. Genetic variation of brain-derived neurotrophic factor (BDNF) in bipolar disorder: case-control study of over 3000 individuals from the UK. Br. J. Psychiatry188, 21–25 (2006).
   PubMed Web of Science ®Google Scholar
• Muller DJ, de Luca V, Sicard T, King N, Strauss J, Kennedy JL. Brain-derived neurotrophic factor (BDNF) gene and rapid-cycling bipolar disorder: family-based association study. Br. J. Psychiatry189, 317–323 (2006).
   PubMed Web of Science ®Google Scholar
• Tramontina J, Frey BN, Andreazza AC, Zandona M, Santin A, Kapczinski F. Val66met polymorphism and serum brain-derived neurotrophic factor levels in bipolar disorder. Mol. Psychiatry12(3), 230–231 (2007).
   PubMed Web of Science ®Google Scholar
• Rosa AR, Frey BN, Andreazza AC et al. Increased serum glial cell line-derived neurotrophic factor immunocontent during manic and depressive episodes in individuals with bipolar disorder. Neurosci. Lett.407(2), 146–150 (2006).
   PubMed Web of Science ®Google Scholar
• Walz JC, Andreazza AC, Frey BN et al. Serum neurotrophin-3 is increased during manic and depressive episodes in bipolar disorder. Neurosci. Lett.415(1), 87–89 (2007).
   PubMed Web of Science ®Google Scholar
• Rajkowska G, Halaris A, Selemon LD. Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder. Biol. Psychiatry49(9), 741–752 (2001).
   PubMed Web of Science ®Google Scholar
• McEwen BS. Protection and damage from acute and chronic stress: allostasis and allostatic overload and relevance to the pathophysiology of psychiatric disorders. Ann. NY Acad. Sci.1032, 1–7 (2004).
   PubMed Web of Science ®Google Scholar
• Phillips ML, Vieta E. Identifying functional neuroimaging biomarkers of bipolar disorder: toward DSM-V. Schizophr. Bull.33(4), 893–904 (2007).
   PubMed Web of Science ®Google Scholar
• Yurgelun-Todd DA, Gruber SA, Kanayama G, Killgore WD, Baird AA, Young AD. fMRI during affect discrimination in bipolar affective disorder. Bipolar Disord.2(3 Pt 2), 237–248 (2000).
   PubMed Web of Science ®Google Scholar
• Malhi GS, Lagopoulos J, Owen AM, Yatham LN. Bipolaroids: functional imaging in bipolar disorder. Acta Psychiatr. Scand. Suppl. (422), 46–54 (2004).
   PubMedGoogle Scholar
• Chen CH, Lennox B, Jacob R et al. Explicit and implicit facial affect recognition in manic and depressed States of bipolar disorder: a functional magnetic resonance imaging study. Biol. Psychiatry59(1), 31–39 (2006).
   PubMed Web of Science ®Google Scholar
• Kauer-Sant’anna M, Yatham LN, Tramontina J et al. Emotional memory in bipolar disorder. Br. J. Psychiatry192, 458–463 (2008).
   PubMed Web of Science ®Google Scholar
• Cahill L, Prins B, Weber M, McGaugh JL. β-adrenergic activation and memory for emotional events. Nature371(6499), 702–704 (1994).
   PubMed Web of Science ®Google Scholar
• Romeo RD, McEwen BS. Stress and the adolescent brain. Ann. NY Acad. Sci.1094, 202–214 (2006).
   PubMed Web of Science ®Google Scholar
• Ongur D, Drevets WC, Price JL. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc. Natl Acad. Sci. USA95(22), 13290–13295 (1998).
   PubMed Web of Science ®Google Scholar
• Uranova NA, Vostrikov VM, Orlovskaya DD, Rachmanova VI. Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. Schizophr. Res.67(2–3), 269–275 (2004).
   PubMed Web of Science ®Google Scholar
• Rajkowska G. Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol. Psychiatry48(8), 766–777 (2000).
   PubMed Web of Science ®Google Scholar
• Cecil KM, DelBello MP, Morey R, Strakowski SM. Frontal lobe differences in bipolar disorder as determined by proton MR spectroscopy. Bipolar Disord.4(6), 357–365 (2002).
   PubMed Web of Science ®Google Scholar
• Winsberg ME, Sachs N, Tate DL, Adalsteinsson E, Spielman D, Ketter TA. Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder. Biol. Psychiatry47(6), 475–481 (2000).
   PubMed Web of Science ®Google Scholar
• Compas BE. Psychobiological processes of stress and coping: implications for resilience in children and adolescents – comments on the papers of Romeo & McEwen and Fisher et al.Ann. NY Acad. Sci.1094, 226–234 (2006).
   PubMed Web of Science ®Google Scholar
• Frey BN, Andreazza AC, Nery FG et al. The role of hippocampus in the pathophysiology of bipolar disorder. Behav. Pharmacol.18(5–6), 419–430 (2007).
   PubMedGoogle Scholar
• Frazier JA, Breeze JL, Makris N et al. Cortical gray matter differences identified by structural magnetic resonance imaging in pediatric bipolar disorder. Bipolar Disord.7(6), 555–569 (2005).
   PubMed Web of Science ®Google Scholar
• Lupien SJ, Evans A, Lord C et al. Hippocampal volume is as variable in young as in older adults: implications for the notion of hippocampal atrophy in humans. Neuroimage34(2), 479–485 (2007).
   PubMed Web of Science ®Google Scholar
• Zammit S, Allebeck P, David AS et al. A longitudinal study of premorbid IQ score and risk of developing schizophrenia, bipolar disorder, severe depression, and other nonaffective psychoses. Arch. Gen. Psychiatry61(4), 354–360 (2004).
   PubMed Web of Science ®Google Scholar
• Reichenberg A, Weiser M, Rapp MA et al. Elaboration on premorbid intellectual performance in schizophrenia: premorbid intellectual decline and risk for schizophrenia. Arch. Gen. Psychiatry62(12), 1297–1304 (2005).
   PubMed Web of Science ®Google Scholar
• Patterson SL, Pittenger C, Morozov A et al. Some forms of cAMP-mediated long-lasting potentiation are associated with release of BDNF and nuclear translocation of phospho-MAP kinase. Neuron32(1), 123–140 (2001).
   PubMed Web of Science ®Google Scholar
• Minichiello L, Korte M, Wolfer D et al. Essential role for TrkB receptors in hippocampus-mediated learning. Neuron24(2), 401–414 (1999).
   PubMed Web of Science ®Google Scholar
• Egan MF, Kojima M, Callicott JH et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell112(2), 257–269 (2003).
   PubMed Web of Science ®Google Scholar
• Neves-Pereira M, Mundo E, Muglia P, King N, Macciardi F, Kennedy JL. The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. Am. J. Hum. Genet.71(3), 651–655 (2002).
   PubMed Web of Science ®Google Scholar
• Sklar P, Gabriel SB, McInnis MG et al. Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor. Mol. Psychiatry7(6), 579–593 (2002).
   PubMed Web of Science ®Google Scholar
• Geller B, Badner JA, Tillman R, Christian SL, Bolhofner K, Cook EH Jr. Linkage disequilibrium of the brain-derived neurotrophic factor Val66Met polymorphism in children with a prepubertal and early adolescent bipolar disorder phenotype. Am. J. Psychiatry161(9), 1698–1700 (2004).
   PubMed Web of Science ®Google Scholar
• Oswald P, Del-Favero J, Massat I et al. Non-replication of the brain-derived neurotrophic factor (BDNF) association in bipolar affective disorder: a Belgian patient-control study. Am. J. Med. Genet. B Neuropsychiatr. Genet.129(1), 34–35 (2004).
   Google Scholar
• Skibinska M, Hauser J, Czerski PM et al. Association analysis of brain-derived neurotrophic factor (BDNF) gene Val66Met polymorphism in schizophrenia and bipolar affective disorder. World J. Biol. Psychiatry5(4), 215–220 (2004).
   PubMed Web of Science ®Google Scholar
• Rybakowski JK, Suwalska A, Skibinska M et al. Prophylactic lithium response and polymorphism of the brain-derived neurotrophic factor gene. Pharmacopsychiatry38(4), 166–170 (2005).
   PubMedGoogle Scholar
• Rybakowski JK, Borkowska A, Skibinska M, Hauser J. Illness-specific association of val66met BDNF polymorphism with performance on Wisconsin Card Sorting Test in bipolar mood disorder. Mol. Psychiatry11(2), 122–124 (2006).
   PubMed Web of Science ®Google Scholar
• Matsuo K, Walls-Bass C, Nicoletti M et al. Brain-derived neurotrophic factor val66met polymorphism and morphometric abnormality in bipolar disorder patients. Biol. Psychiatry61(Suppl. 1), S141 (2007).
   Google Scholar
• Frey BN, Walss-Bass C, Stanley JA et al. Brain-derived neurotrophic factor val66met polymorphism affects prefrontal energy metabolism in bipolar disorder. Neuroreport18(15), 1567–1570 (2007).
   PubMedGoogle Scholar
• Hariri AR, Goldberg TE, Mattay VS et al. Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J. Neurosci.23(17), 6690–6694 (2003).
   PubMed Web of Science ®Google Scholar
• Szeszko PR, Lipsky R, Mentschel C et al. Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation. Mol. Psychiatry10(7), 631–636 (2005).
   PubMed Web of Science ®Google Scholar
• Pezawas L, Verchinski BA, Mattay VS et al. The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J. Neurosci.24(45), 10099–10102 (2004).
   PubMed Web of Science ®Google Scholar
• Nemoto K, Ohnishi T, Mori T et al. The Val66Met polymorphism of the brain-derived neurotrophic factor gene affects age-related brain morphology. Neurosci. Lett.397(1–2), 25–29 (2006).
   PubMed Web of Science ®Google Scholar
• Bath KG, Lee FS. Variant BDNF (Val66Met) impact on brain structure and function. Cogn. Affect. Behav. Neurosci.6(1), 79–85 (2006).
   PubMed Web of Science ®Google Scholar
• Aicardi G, Argilli E, Cappello S et al. Induction of long-term potentiation and depression is reflected by corresponding changes in secretion of endogenous brain-derived neurotrophic factor. Proc. Natl Acad. Sci. USA101(44), 15788–15792 (2004).
   PubMed Web of Science ®Google Scholar
• von Bohlen und Halbach O, Krause S, Medina D, Sciarretta C, Minichiello L, Unsicker K. Regional- and age-dependent reduction in trkB receptor expression in the hippocampus is associated with altered spine morphologies. Biol. Psychiatry59(9), 793–800 (2006).
   PubMedGoogle Scholar
• Castren E, Voikar V, Rantamaki T. Role of neurotrophic factors in depression. Curr. Opin. Pharmacol.7(1), 18–21 (2007).
   PubMed Web of Science ®Google Scholar
• Coyle JT, Duman RS. Finding the intracellular signaling pathways affected by mood disorder treatments. Neuron38(2), 157–160 (2003).
   PubMed Web of Science ®Google Scholar
• Saarelainen T, Hendolin P, Lucas G et al. Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. J. Neurosci.23(1), 349–357 (2003).
   PubMed Web of Science ®Google Scholar
• Shirayama Y, Chen AC, Nakagawa S, Russell DS, Duman RS. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J. Neurosci.22(8), 3251–3261 (2002).
   PubMed Web of Science ®Google Scholar
• Fukumoto T, Morinobu S, Okamoto Y, Kagaya A, Yamawaki S. Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain. Psychopharmacology (Berl.)158(1), 100–106 (2001).
   PubMed Web of Science ®Google Scholar
• Frey BN, Andreazza AC, Cereser KM et al. Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania. Life Sci.79(3), 281–286 (2006).
   PubMed Web of Science ®Google Scholar
• Eisch AJ, Bolanos CA, de Wit J et al. Brain-derived neurotrophic factor in the ventral midbrain-nucleus accumbens pathway: a role in depression. Biol. Psychiatry54(10), 994–1005 (2003).
   PubMed Web of Science ®Google Scholar
• Berton O, McClung CA, Dileone RJ et al. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science311(5762), 864–868 (2006).
   PubMed Web of Science ®Google Scholar
• Karege F, Bondolfi G, Gervasoni N, Schwald M, Aubry JM, Bertschy G. Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. Biol. Psychiatry57(9), 1068–1072 (2005).
   PubMed Web of Science ®Google Scholar
• Noga O, Englmann C, Hanf G, Grutzkau A, Seybold J, Kunkel G. The production, storage and release of the neurotrophins nerve growth factor, brain-derived neurotrophic factor and neurotrophin-3 by human peripheral eosinophils in allergics and non-allergics. Clin. Exp. Allergy33(5), 649–654 (2003).
   PubMed Web of Science ®Google Scholar
• Nakahashi T, Fujimura H, Altar CA et al. Vascular endothelial cells synthesize and secrete brain-derived neurotrophic factor. FEBS Lett.470(2), 113–117 (2000).
   PubMed Web of Science ®Google Scholar
• Pan W, Banks WA, Fasold MB, Bluth J, Kastin AJ. Transport of brain-derived neurotrophic factor across the blood–brain barrier. Neuropharmacology37(12), 1553–1561 (1998).
   PubMed Web of Science ®Google Scholar
• Karege F, Schwald M, Cisse M. Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci. Lett.328(3), 261–264 (2002).
   PubMed Web of Science ®Google Scholar
• Dawood T, Anderson J, Barton D et al. Reduced overflow of BDNF from the brain is linked with suicide risk in depressive illness. Mol. Psychiatry12(11), 981–983 (2007).
   PubMed Web of Science ®Google Scholar
• Lang UE, Hellweg R, Seifert F, Schubert F, Gallinat J. Correlation between serum brain-derived neurotrophic factor level and an in vivo marker of cortical integrity. Biol. Psychiatry62(5), 530–535 (2007).
   PubMed Web of Science ®Google Scholar
• Chen B, Dowlatshahi D, MacQueen GM, Wang JF, Young LT. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol. Psychiatry50(4), 260–265 (2001).
   PubMed Web of Science ®Google Scholar
• Moore GJ, Bebchuk JM, Wilds IB, Chen G, Manji HK. Lithium-induced increase in human brain grey matter. Lancet356(9237), 1241–1242 (2000).
   PubMed Web of Science ®Google Scholar
• Sassi RB, Nicoletti M, Brambilla P et al. Increased gray matter volume in lithium-treated bipolar disorder patients. Neurosci. Lett.329(2), 243–245 (2002).
   PubMed Web of Science ®Google Scholar
• Bearden CE, Thompson PM, Dalwani M et al. Greater cortical gray matter density in lithium-treated patients with bipolar disorder. Biol. Psychiatry62(1), 7–16 (2007).
   PubMed Web of Science ®Google Scholar
• Bearden CE, Thompson PM, Dutton RA et al. Three-dimensional mapping of hippocampal anatomy in unmedicated and lithium-treated patients with bipolar disorder. Neuropsychopharmacology33(6), 1229–1238 (2008).
   PubMed Web of Science ®Google Scholar
• Yucel K, McKinnon MC, Taylor VH et al. Bilateral hippocampal volume increases after long-term lithium treatment in patients with bipolar disorder: a longitudinal MRI study. Psychopharmacology (Berl.)195(3), 357–367 (2007).
   PubMedGoogle Scholar
• Yucel K, Taylor VH, McKinnon MC et al. Bilateral hippocampal volume increase in patients with bipolar disorder and short-term lithium treatment. Neuropsychopharmacology33(2), 361–367 (2008).
   PubMed Web of Science ®Google Scholar
• Nibuya M, Morinobu S, Duman RS. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J. Neurosci.15(11), 7539–7547 (1995).
   PubMed Web of Science ®Google Scholar
• Zarate CA Jr, Singh JB, Carlson PJ et al. Efficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: a pilot study. Bipolar Disord.9(6), 561–570 (2007).
   PubMed Web of Science ®Google Scholar
• Zarate CA Jr, Quiroz JA, Singh JB et al. An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression. Biol. Psychiatry57(4), 430–432 (2005).
   PubMed Web of Science ®Google Scholar
• Zai G, Mundo E, Strauss J, Wong GW, Kennedy JL. Brain-derived neurotrophic factor (BDNF) gene not associated with antidepressant-induced mania. Bipolar Disord.9(5), 521–525 (2007).
   PubMedGoogle Scholar
• Mondimore FM. Kraepelin and manic-depressive insanity: an historical perspective. Int. Rev. Psychiatry17(1), 49–52 (2005).
   PubMed Web of Science ®Google Scholar
• McGrath JJ, Feron FP, Burne TH, Mackay-Sim A, Eyles DW. The neurodevelopmental hypothesis of schizophrenia: a review of recent developments. Ann. Med.35(2), 86–93 (2003).
   PubMed Web of Science ®Google Scholar
• Kapczinski F, Vieta E, Andreazza AC et al. Allostatic load in bipolar disorder: implications for pathophysiology and treatment. Neurosci. Biobehav Rev.32(4), 675–692 (2008).
   PubMed Web of Science ®Google Scholar
• Post RM. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am. J. Psychiatry149(8), 999–1010 (1992).
   PubMed Web of Science ®Google Scholar
• Post RM. Kindling and sensitization as models for affective episode recurrence, cyclicity, and tolerance phenomena. Neurosci. Biobehav. Rev.31(6), 858–873 (2007).
   PubMed Web of Science ®Google Scholar
• Gama CS, Andreazza AC, Kunz M, Berk M, Belmonte-de-Abreu PS, Kapczinski F. Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder. Neurosci. Lett.420(1), 45–48 (2007).
   PubMed Web of Science ®Google Scholar
• Berk M, Hallam KT, McGorry PD. The potential utility of a staging model as a course specifier: a bipolar disorder perspective. J. Affect. Disord.100(1–3), 279–281 (2007).
   PubMed Web of Science ®Google Scholar
• Vieta E, Phillips ML. Deconstructing bipolar disorder: a critical review of its diagnostic validity and a proposal for DSM-V and ICD-11. Schizophr. Bull.33(4), 886–892 (2007).
   PubMed Web of Science ®Google Scholar